vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021

vTv Therapeutics reports 2021 executive compensation

By ExecPay News

Published: May 2, 2022

vTv Therapeutics reported fiscal year 2021 executive compensation information on May 2, 2022.
In 2021, three executives at vTv Therapeutics received on average a compensation package of $2M, a 107% increase compared to previous year.
Average pay of disclosed executives at vTv Therapeutics
Deepa Prasad, Chief Executive Officer, received $3.3M in total. 96% of Prasad's compensation, or $3.2M, was in option awards. Prasad also received $133K in salary.
Stephen L. Holcombe, Chief Executive Officer, received a compensation package of $1.9M, which increased by 36% compared to previous year. 41% of the compensation package, or $780K, was in option awards.
Rudy C. Howard, Chief Financial Officer, earned $881K in 2021, a 6% decrease compared to previous year.

Related executives

Deepa Prasad

vTv Therapeutics

Chief Executive Officer

Stephen Holcombe

vTv Therapeutics

Chief Executive Officer

Rudy Howard

vTv Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on May 2, 2022.